Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
4.550
+0.060 (1.34%)
At close: May 29, 2026, 4:00 PM EDT
4.560
+0.010 (0.22%)
After-hours: May 29, 2026, 7:55 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
227.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | 37 | 3,700.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| Keros Therapeutics | 87 |
| Camp4 Therapeutics | 48 |
| NovaBridge Biosciences | 30 |
| Whitehawk Therapeutics | 23 |
HELP News
- 4 weeks ago - CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 4 weeks ago - Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - GlobeNewsWire
- 4 weeks ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 5 weeks ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire
- 5 weeks ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 5 weeks ago - Helus ‘welcomes’ Executive Order for accelerating psychedelic research - TheFly
- 5 weeks ago - Helus Pharma announces Cola is stepping down as CEO, appoints So as Interim CEO - TheFly
- 5 weeks ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire